The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
November 12th 2024
Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
Study Shows Benefits of Annual Mammography Exams from 40 to 79 Years of Age
February 21st 2024In comparison to biennial mammography screening between the ages of 50 to 74, researchers found that annual screening between 40 and 79 years of age resulted in a greater than 16 percent higher reduction in breast cancer mortality.
Moving Beyond Mammography for Screening and Staging of Invasive Lobular Carcinoma
February 16th 2024For women with dense breasts, only 25 percent of breast radiologists are confident in the use of mammography for diagnosing invasive lobular carcinoma, according to newly published survey results from the Society of Breast Imaging.
Assessing the Potential of Positron Emission Mammography: An Interview with Vivianne Freitas, MD
February 12th 2024In a recent interview, Vivianne Freitas, M.D., discussed new research findings on positron emission mammography (PEM), pertinent benefits of the technology and its potential as a viable alternative in the future to conventional imaging techniques for breast cancer screening.
Can Positron Emission Mammography Have an Impact in Diagnosing Invasive Breast Cancer?
February 9th 2024Findings from a new pilot study showed that low-dose positron emission mammography (PEM) detected 96 percent of malignant index lesions and had a 46 percent lower false-positive rate in comparison to breast MRI.
Key Takeaways from Multiple Radiology Societies on AI Assessment and Integration
January 22nd 2024In a recently issued statement from multiple radiology societies including the RSNA and ACR, researchers offer practical advice for evaluating artificial intelligence (AI) tools, implementing AI into current workflows and monitoring of the technology to help ensure optimal benefit and effectiveness.
Study: Abbreviated MRI and DBT Offer Comparable Breast Cancer Detection in Dense Breasts
January 17th 2024For women with dense breasts, abbreviated breast MRI and digital breast tomosynthesis (DBT) both offered greater than 98 percent sensitivity rates and greater than 94 percent negative predictive values (NPVs) for breast cancer detection, according to newly published research.
Can a Genetic Model Help Reduce Overuse of Mammography in Women at Low Risk for Breast Cancer?
January 2nd 2024In a study assessing the use of a genetic risk stratification model to estimate breast cancer risk in over 25,000 women, researchers found that 0.69 percent of women at low genetic risk were diagnosed with breast cancer by the age of 45 and 1.41 percent of this group were diagnosed by the age of 58.
Mammography Surveillance: Can Screening DBT Have an Impact After Breast Cancer Treatment?
December 22nd 2023In a study of over 30,000 screening digital breast tomosynthesis (DBT) exams for over 8,000 women, researchers found a specificity rate of 95.1 percent, a false negative rate of 2.1 (per 1,000 exams) and an abnormal interpretation rate (AIR) of 5.7 percent.
Can ChatGPT and Bard Bolster Decision-Making for Cancer Screening in Radiology?
December 21st 2023In a study examining the potential of the large language models ChatGPT-4 and Bard to follow ACR Appropriateness Criteria for breast cancer, lung cancer, ovarian cancer and colorectal cancer screening, researchers noted “impressive accuracy in making radiologic clinical decisions.”
Is Contrast-Enhanced Mammography a Viable Option for Diagnosing Invasive Lobular Carcinoma?
December 15th 2023Contrast-enhanced mammography had a 98 percent sensitivity rate for diagnosing invasive lobular carcinoma and provided high conspicuity for 82 percent of detected lesions, according to research presented at the recent Radiological Society of North America (RSNA) conference.